TABLE 1.
Demographic and clinical characteristics of the study.
| Sedation | Non–sedation | Total | p | |
|---|---|---|---|---|
| N = 29 (25.4%) | N = 85 (74.6%) | N = 114 | ||
| Age, month | 28 (24 to 44) | 24 (14.5 to 37) | 25 (17 to 39) | 0.098 |
| Sex, male | 19 (65.5) | 59 (69.4) | 78 (68.4) | 0.697 |
| Clinical presentation | ||||
| Duration of symptom, h | 6 (2 to 24) | 5 (1.75 to 12) | 5 (2 to 12) | 0.125 |
| Abdominal pain | 24 (82.8) | 65 (76.5) | 89 (78.1) | 0.480 |
| Vomiting | 9 (31) | 39 (45.9) | 48 (42.1) | 0.162 |
| Hematochezia | 2 (6.9) | 10 (11.8) | 12 (10.5) | 0.728 |
| Past history of intussusception | 5 (17.2) | 10 (11.8) | 15 (13.2) | 0.451 |
| Pathologic leading point | 1 (3.4) | 1 (1.2) | 2 (1.8) | — |
| Laboratory test | ||||
| WBC, ×103/μL | 10.4 (9.2 to 13.9) | 12.2 (9.0 to 14.8) | 11.5 (9.2 to 14.6) | 0.299 |
| CRP, mg/dL | 0.26 (0.1 to 1) | 0.18 (0.1 to 0.7) | 0.2 (0.1 to 0.72) | 0.497 |
| Glucose, mg/dL | 93 (82 to 107) | 102 (87 to 113) | 100 (86 to 111) | 0.186 |
| pH | 7.41 (7.38 to 7.46) | 7.41 (7.36 to 7.44) | 7.41 (7.37 to 7.44) | 0.277 |
| Bicarbonate, mmol/L | 20.6 (17.5 to 21.9) | 20.1 (18.1 to 21.2) | 20.2 (18.3 to 21.3) | 0.609 |
| BE, mmol/L | −3 (−5.1 to −1.7) | −4 (−5.5 to −2.6) | −4 (−5.5 to −2.5) | 0.108 |
| Lactate, mmol/L | 1.6 (1.2 to 2) | 1.6 (1.3 to 2.1) | 1.6 (1.3 to 2.1) | 0.789 |
Note: Values are presented as numbers (%) or medians (interquartile range).
Abbreviations: BE, Base excess; CRP, C‐reactive protein.